Crisantaspase

ATC L01XX02 · 4 markets · 7 records

Crisantaspase 4 markets · 7 records Forms

AU 3 records · 2 strengths

  • 20 mg/mLinjectionENRYLAZE recombinant crisantaspase 10 mg/0.5 mL solution for injection/infusion vial unknown

Records without a stated strength · 1 ENRYLAZE、ERWINASE

GB 2 records · 2 strengths

  • 10 mg/0.5 mLinjectionEnrylaze 10mg/0.5ml solution for injection vials

Records without a stated strength · 1 Erwinase 10,000unit powder for solution for injection vials

CA 1 records · 1 strengths

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

    Records without a stated strength · 1 ENRYLAZE

    The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

    Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

    A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.